Literature DB >> 9059178

Surfactant improves lung function and mitigates bacterial growth in immature ventilated rabbits with experimentally induced neonatal group B streptococcal pneumonia.

E Herting1, B Sun, C Jarstrand, T Curstedt, B Robertson.   

Abstract

AIMS: To study the influence of surfactant on lung function and bacterial proliferation in immature newborn rabbits with experimental group B streptococcal (GBS) pneumonia.
METHODS: Preterm rabbit fetuses (gestational age 28 days) underwent tracheotomy and were mechanically ventilated in a warmed body plethysmograph that permitted measurement of lung-thorax compliance. Fifteen minutes after the onset of ventilation the animals received either GBS or saline intratracheally; at 30 minutes, a bolus of saline or 200 mg/kg of a porcine surfactant (Curosurf) was administered via the airway. Bacterial proliferation was evaluated in lung homogenate at the end of the experiments and the results expressed as mean log10 cfu/g lung (SD). Animals receiving only saline (n = 20) or saline and surfactant (n = 20) served as controls.
RESULTS: The average survival time was about three hours in all groups. Infected animals receiving surfactant (n = 22) had significantly less bacterial growth (9.09 (0.45) vs 9.76 (0.91)) and improved lung function (compliance: 0.61 (0.14) vs 0.34 (0.19) ml/kg. cm H2O) than infected rabbits receiving saline at 30 minutes (n = 22).
CONCLUSION: Surfactant improves lung function and mitigates bacterial growth in preterm rabbits infected with group B streptococci.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9059178      PMCID: PMC1720614          DOI: 10.1136/fn.76.1.f3

Source DB:  PubMed          Journal:  Arch Dis Child Fetal Neonatal Ed        ISSN: 1359-2998            Impact factor:   5.747


  24 in total

1.  Properties of high and low density subpopulations of group B streptococci: enhanced virulence of the low density variant.

Authors:  S Håkansson; A M Bergholm; S E Holm; B Wagner; M Wagner
Journal:  Microb Pathog       Date:  1988-11       Impact factor: 3.738

2.  Correlation of clinical and pathologic findings in early onset neonatal group B streptococcal infection with disease severity and prediction of outcome.

Authors:  N R Payne; B A Burke; D L Day; P D Christenson; T R Thompson; P Ferrieri
Journal:  Pediatr Infect Dis J       Date:  1988-12       Impact factor: 2.129

3.  A comparison of early-onset group B steptococcal neonatal infection and the respiratory-distress syndrome of the newborn.

Authors:  R C Ablow; S G Driscoll; E L Effmann; I Gross; C J Jolles; R Uauy; J B Warshaw
Journal:  N Engl J Med       Date:  1976-01-08       Impact factor: 91.245

4.  Surfactant therapy of newborn rabbits impairs lung macrophage bactericidal activity.

Authors:  M P Sherman; J B D'Ambola; E E Aeberhard; C T Barrett
Journal:  J Appl Physiol (1985)       Date:  1988-07

5.  Pulmonary surfactant-associated protein A enhances the surface activity of lipid extract surfactant and reverses inhibition by blood proteins in vitro.

Authors:  A M Cockshutt; J Weitz; F Possmayer
Journal:  Biochemistry       Date:  1990-09-11       Impact factor: 3.162

6.  Intratracheal surfactant administration restores gas exchange in experimental adult respiratory distress syndrome associated with viral pneumonia.

Authors:  G J van Daal; K L So; D Gommers; E P Eijking; R B Fiévez; M J Sprenger; D W van Dam; B Lachmann
Journal:  Anesth Analg       Date:  1991-05       Impact factor: 5.108

7.  Surfactant treatment of full-term newborns with respiratory failure.

Authors:  R L Auten; R H Notter; J W Kendig; J M Davis; D L Shapiro
Journal:  Pediatrics       Date:  1991-01       Impact factor: 7.124

8.  Application of a new ventilator-multi-plethysmograph system for testing efficacy of surfactant replacement in newborn rabbits.

Authors:  B Sun; T Kobayashi; T Cursted; G Grossmann; B Robertson
Journal:  Eur Respir J       Date:  1991-03       Impact factor: 16.671

9.  Bronchoscopic surfactant administration in patients with severe adult respiratory distress syndrome and sepsis.

Authors:  D Walmrath; A Günther; H A Ghofrani; R Schermuly; T Schneider; F Grimminger; W Seeger
Journal:  Am J Respir Crit Care Med       Date:  1996-07       Impact factor: 21.405

10.  Proteolytic inactivation of dog lung surfactant-associated proteins by neutrophil elastase.

Authors:  U Pison; E K Tam; G H Caughey; S Hawgood
Journal:  Biochim Biophys Acta       Date:  1989-09-15
View more
  5 in total

1.  Lipid peroxidation of lung surfactant in experimental neonatal group B streptococcal pneumonia.

Authors:  R K L Bouhafs; C Jarstrand; B Robertson
Journal:  Lung       Date:  2004       Impact factor: 2.584

2.  Surfactant Therapy for Early Onset Pneumonia in Late Preterm and Term Neonates Needing Mechanical Ventilation.

Authors:  Sujata Deshpande; Pradeep Suryawanshi; Kunal Ahya; Rajesh Maheshwari; Samir Gupta
Journal:  J Clin Diagn Res       Date:  2017-08-01

3.  Lysophosphatidylcholine abrogates the CR1 preserving effect of surfactant on quartz-exposed human granulocytes.

Authors:  G Zetterberg; T Curstedt; J Lundahl; A Eklund
Journal:  Inflammation       Date:  1999-04       Impact factor: 4.092

Review 4.  Bacterial and Host Determinants of Group B Streptococcal Infection of the Neonate and Infant.

Authors:  Anna Furuta; Alyssa Brokaw; Gygeria Manuel; Matthew Dacanay; Lauren Marcell; Ravin Seepersaud; Lakshmi Rajagopal; Kristina Adams Waldorf
Journal:  Front Microbiol       Date:  2022-02-21       Impact factor: 6.064

5.  Group B streptococcal beta-hemolysin/cytolysin directly impairs cardiomyocyte viability and function.

Authors:  Mary E Hensler; Shigeki Miyamoto; Victor Nizet
Journal:  PLoS One       Date:  2008-06-18       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.